Comparison of modification sites formed on human serum albumin at various stages of glycation

Clinica Chimica Acta

Volumn 412, Issue 3-4, 2011, Pages 277-285

  Barnaby, Omar S ^a   Cerny, Ronald L ^a   Clarke, William ^b   Hage, David S ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Glycation related modifications; Human serum albumin; Matrix assisted laser desorption ionization time of flight mass spectrometry; Non enzymatic glycation

Indexed keywords

ARGININE; GLUCOSE; HUMAN SERUM ALBUMIN; LYSINE;

AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; GLYCATION; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN MODIFICATION;

AMINO ACID SEQUENCE; BINDING SITES; DIABETES MELLITUS; GLYCOSYLATION; HUMANS; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS; PROTEIN CONFORMATION; SERUM ALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 78650250717     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.10.018     Document Type: Article

References (54)

1. Li W., Ota K., Nakamura J., Naruse K., Nakashima E., Oiso Y., et al. Antiglycation effect of glyclazide on in vitro AGE formation from glucose and methylglyoxal. Exp Biol Med 2008, 233:176-179.
2. Peters T. All about albumin: biochemistry, genetics, and medical applications 1996, Academic Press, San Diego.
3. Makita Z., Vlassara H., Cerami A., Bucala R. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 1992, 267:5133-5138.
4. Syrovy I. Glycation of albumin: reaction with glucose, fructose, galactose, ribose or glyceraldehyde measured using four methods. J Biochem Biophys Meth 1994, 28:115-121.
5. Thornalley P.J., Langborg A., Minhas H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999, 344:109-116.
6. Magalhaes P.M., Appell H.J., Duarte J.A. Involvement of advanced glycation end products in the pathogenesis of diabetic complications: the protective role of regular physical activity. Eur Rev Aging Phys Act 2008, 5:17-29.
7. Hayashi T., Mase S., Namiki M. Formation of three-carbon sugar fragment at an early stage of the browning reaction of sugar with amines or amino acids. Agric Biol Chem 1986, 50:1959-1964.
8. Zhang Q., Ames J.M., Smith R.D., Baynes J.W., Metz T.O. A perspective on the maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. J Proteome Res 2009, 8:754-769.
9. Saito M., Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 2010, 21:195-214.
10. Sell D.R., Nemet I., Monnier V.M. Partial characterization of the molecular nature of collagen-linked flourescence: role of diabetes and end-stage renal disease. Arch Biochem Biophys 2010, 493:192-206.
11. Bank R.A., Baylis M.T., Lafeber F.P., Maroudas A., Tekoppele J.M. Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. the age-related increase in non-enzymatic glycation affects iomechanical properties of cartilage. Biochem J 1998, 330:345-351.
12. Monnier V.M., Kohn R.R., Cerami A. Accelerated age related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci 1984, 81:583-587.
13. Jansirani, Anathanaryanan P.H. A comparitive study of lens protein glycation in various forms of cataracht. Indian J Clin Biochem 2004, 19:110-112.
14. Lewis B.S., Harding J.J. The effects of aminoguanidine on the glycation (non-enzymatic glycosylation) of lens proteins. Exp Eye Res 1990, 50:463-467.
15. Turk Z., Misur I., Turk N. Temporal association between lens protein glycation and cataract development in diabetic rats. Acta Diabetol 1997, 34:49-54.
16. Biroccio A., Urbani A., Massoud R., di Ilio C., Sacchetta P., Bernardini S., et al. A quantitative method for the analysis of glycated and glutathionylated hemoglobin by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Anal Biochem 2005, 336:279-288.
17. Nakanishi T., Miyazaki A., Kishikawa M., Yasuda M. Quantification of glycated hemoglobin by electrospray ionization mass spectrometry. J Mass Spectrom 1997, 32:773-778.
18. Chandalia H.B., Krishnaswamy P.R. Glycated hemoglobin. Curr Sci 2002, 83:1522-1532.
19. Rodkey F.L. Direct spectrophotometric determination of albumin in human serum. Clin Chem 1965, 11:478-487.
20. Ghuman J., Zunszain P.A., Petitpas I., Bhattachara A.A., Otagiri M., Curry S. Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 2005, 353:38-52.
21. Koyama H., Sugioka N., Uno A., Mori S., Nakajima K. Effects of glycosylation of hypoglycemic drug binding to serum albumin. Biopharm Drug Dispos 1997, 18:791-801.
22. Vorum H., Fisker K., Otagiri M., Pedersen A.O., Hansen U.K. Calcium ion binding to clinically relevant chemical modifications of human serum albumin. Clin Chem 1995, 41:1654-1661.
23. Chiou Y.J., Tomer K.B., Smith P.C. Effect of nonenzymatic glycation of albumin and superoxide dismutase by glucuronic acid and suprofen acyl glucuronide on their functions in vitro. Chem Biol Interact 1999, 121:141-159.
24. Nakajou K., Watanabe H., Kragh-Hansen U., Maruyama T., Otagiri M. The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochim Biophys Acta 2003, 1623:88-97.
25. Shaklai N., Garlick R.L., Bunn H.F. Nonenzymatic glycosylation of human serum albumin alters its confirmation and function. J Biol Chem 1984, 259:3812-3817.
26. Iberg N., Fluckiger R. Nonenzymatic glycosylation of albumin in vivo. J Biol Chem 1986, 261:13542-13545.
27. Robb D.A., Olufemi S.O., Williams D.A., Midgley J.M. Identification of glycation at the N-terminus of albumin by gas chromatography-mass spectrometry. Biochem J 1989, 261:871-878.
28. Ahmed N., Dobler D., Dean M., Thornalley P.J. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem 2005, 280:5724-5732.
29. Wa C., Cerny R.L., Clarke W.A., Hage D.S. Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chim Acta 2007, 385:48-60.
30. 18O labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chim Acta 2010, 411:1102-1110.
31. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diab Care 2004, 25:S5-S20.
32. Turner R.C., Cull C.A., Frighi V., Holman R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. J Am Med Assoc 1999, 281:2005-2012.
33. Wa C., Cerny R., Hage D.S. Obtaining high sequence coverage in matrix-assisted laser desorption time-of-flight mass spectrometry for studies of protein modification: Analysis of human serum albumin as a model. Anal Biochem 2006, 349:229-241.
34. Perkins D.N., Pappin D.J.C., Creasy D.M., Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
35. Lapolla A., Fedele D., Reitano R., Aricò N.C., Seraglia R., Traldi P., et al. Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J Am Soc Mass Spectrom 2004, 15:496-509.
36. Ney K.A., Karen J., Colley K.J., Pizzob S.V. The standardization of the thiobarbituric acid assay for nonenzymatic glucosylation of human serum albumin. Anal Biochem 1981, 118:294-300.
37. Voziyan P.A., Khalifah R.G., Thibaudeau C., Yildiz A., Jacob J., Serianni A.S., et al. Modification of proteins in vitro by physiological levels of glucose. J Biol Chem 2003, 278:46616-46624.
38. Barzegar A., Moosavi-Movahedi A.A., Sattarahmady N. Spectroscopic studies of the effects of glycation of human serum albumin on L-trp binding. Protein Pept Lett 2007, 14:13-18.
39. Joseph K.S., Hage D.S. The effects of glycation on the binding of human serum albumin to warfarin and l-tryptophan. J Pharm Biomed Anal 2010, 53:811-818.
40. Kouzuma T., Usami T., Yamakoshi M., Takahashi M., Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 2002, 324:61-71.
41. Armbuster D.A. Fructosaminase: structure, analysis and clinical usefulness. Clin Chem 1987, 33:2153-2163.
42. Zubarev R., Manns M. On the proper use of mass accuracy in proteomics. Mol Cell Proteomics 2007, 6:377-381.
43. Syrovy I. Glycation of albumin: reaction with glucose, fructose, galactose, ribose or glyceraldehyde measured using four methods. J Biochem Biophys Meth 1994, 28:115-121.
44. Lapolla A., Fedele D., Seraglia R., Catinella S., Baldo L., Aronica R., et al. A new effective method for the evaluation of glycated intact plasma proteins in diabetic subjects. Diabetologia 1995, 38:1076-1081.
45. Zhang Y., Cocklin R.R., Bidasee K.R., Wang M. Rapid determination of advanced glycation end products using MALDI-TOF-MS and PERL script peptide searching algorithm. J Biomol Tech 2003, 14:224-230.
46. Sugio S., Kashima A., Mochizuki S., Kobayashi K. Crystal structure of human serum albumin at 2.5Å resolution. Protein Eng 1999, 12:439-446.
47. Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996, 14:33-38.
48. a values. Proteins 2005, 61:704-721.
49. Thornalley P.J. Dicarbonyl intermediates in the maillard reaction. Ann NY Acad Sci 2005, 1043:111-117.
50. Joseph KS, Anguizola J, Hage DS. Binding of tolbutamide to glycated human serum albumin. J Pharm Biomed Anal 2011;54:426-32.
51. Joseph K.S., Anguizola J., Jackson A.J., Hage D.S. Chromatographic analysis of acetohexamide binding to glycated human serum albumin. J Chromatogr B 2010, 878:2775-2781.
52. Curry S., Mandelkow H., Brick P., Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 1998, 5:827-835.
53. Mandula H., Parepally J.M.R., Feng R., Smith Q.R. Role of site-specific binding to plasma albumin in drug availability to brain. J Pharmacol Exp Therapeut 2006, 317:667-675.
54. Doucet J., Fresel J., Hue G., Moore N. Protein binding of digitoxin, valproate and phenytoin in sera from diabetics. Eur J Clin Pharmacol 1993, 45:577-579.